Search results for "PULMONARY"

showing 10 items of 3030 documents

Frequency of thrombosis is higher in MPN patients who develop second cancer than in controls

2019

Introduction Malignancy can be heralded by unprovoked venous thromboembolism (VTE) but also by arterial thrombosis. To date it is unknown whether this association is present also in myeloproliferative neoplasms (MPN), in which arterial thrombosis is more frequent that venous thrombosis and solid tumors are reported with an increased frequency. The MPN-K nested case-control study addressed the impact of cytoreductive drugs on the risk of developing second cancer in MPN patients (Barbui T et al, Leukemia 2019); here we re-examined the study database to evaluate the frequency and type of vascular complications in MPN patients with second cancer excluding leukemia and to establish whether arter…

medicine.medical_specialtybusiness.industryImmunologyCancerCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyThrombosisPulmonary embolismLog-rank testVenous thrombosisLeukemiaInternal medicinemedicineCarcinomaThrombusbusiness
researchProduct

Objective Assessment of Pulmonary Embolism Can Be Deferred without Increased Risk

2005

Abstract Background. Management of patients with suspected Pulmonary Embolism (PE) is problematic if diagnostic imaging is not available. Pretest Clinical Probability (PCP) and D-dimer (D-d) assessment were shown to be useful to identify those high risk patients for whom empirical, protective anticoagulation is indicated (Siragusa S et al. Arch Intern Med2004;164:2477–82). Objective of the study. In consecutive patients with suspected PE, we evaluated whether PCP and D-d assessment, together with the use of low molecular weight heparins (LMWHs), allow objective appraisal of PE to be deferred for up to 72 hours. Methods. In case of deferment of diagnostic imaging for PE, patients identified …

medicine.medical_specialtybusiness.industryImmunologyCell BiologyHematologymedicine.diseaseBiochemistryVentilation/perfusion ratioConfidence intervalSurgeryPulmonary embolismObjective assessmentInternal medicineAntithromboticMedicinebusinessPerfusionVenous thromboembolismFibrinolytic agent
researchProduct

High-Frequency Oscillatory Ventilation In Patients With Chronic Obstructive Pulmonary Disease

2011

medicine.medical_specialtybusiness.industryInternal medicineCardiologymedicinePulmonary diseaseIn patientbusinessHigh frequency oscillatory ventilationA48. CLINICAL RESEARCH
researchProduct

P5017Factors associated with a negative D-dimer test in patients diagnosed with acute symptomatic pulmonary embolism

2019

Abstract Background The recommended diagnostic strategy for suspected acute pulmonary embolism (PE) combines the assessment of pre-test probability, D-dimer level, and -if indicated- computed tomography pulmonary angiography. Purpose To evaluate the frequency and potential explanations for negative D-dimer tests in patients diagnosed with acute PE. Methods The multicentre Follow-up of Acute Pulmonary Embolism (FOCUS) cohort study prospectively enrolled 1,100 consecutive patients diagnosed with acute symptomatic PE; two-year follow-up is ongoing. The items of the Simplified revised Geneva Score and the D-dimer levels at diagnosis have been prospectively collected, but they did not necessaril…

medicine.medical_specialtybusiness.industryInternal medicineD-dimerMedicineIn patientCardiology and Cardiovascular Medicinebusinessmedicine.diseaseGastroenterologyPulmonary embolismEuropean Heart Journal
researchProduct

Chronic Thromboembolic Pulmonary Hypertension: Results From A Prospective, Observational European Registry

2010

medicine.medical_specialtybusiness.industryInternal medicineMedicineChronic thromboembolic pulmonary hypertensionObservational studybusinessA57. CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: DIAGNOSIS, TREATMENT, AND PATHOGENESIS
researchProduct

P2772The rule-out criteria for chronic thromboembolic pulmonary hypertension can identify patients without haemodynamic abnormalities and functional …

2019

Abstract Background Up to one-third of patients report persisting hemodynamic abnormalities and functional limitation over long-term follow-up after acute pulmonary embolism (PE). Purpose We tested whether a validated algorithm designed to rule-out chronic thromboembolic pulmonary hypertension (CTEPH) after acute PE can be used for identifying patients at lower risk of presenting with persisting symptoms and echocardiographic abnormalities. Methods The multicentre Follow-up of Acute Pulmonary Embolism (FOCUS) cohort study prospectively enrolled 1,100 consecutive patients diagnosed with acute symptomatic PE; two-year follow-up is ongoing. We focused on the scheduled visits for 3- and 12-mont…

medicine.medical_specialtybusiness.industryInternal medicinemedicineCardiologyHemodynamicsChronic thromboembolic pulmonary hypertensionCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Diagnosis of pulmonary embolism: progress after many YEARS

2017

medicine.medical_specialtybusiness.industryMEDLINEGeneral Medicine030204 cardiovascular system & hematologymedicine.diseasePulmonary embolism03 medical and health sciences0302 clinical medicineText miningmedicine030212 general & internal medicineIntensive care medicinebusinessThe Lancet
researchProduct

Pulmonary thromboembolism associated with the use of new antipsychotics in a paediatric patient.

2020

medicine.medical_specialtybusiness.industryMEDLINEText miningThromboembolismPediatrics Perinatology and Child HealthmedicineHumansIntensive care medicinebusinessChildPulmonary EmbolismPaediatric patientsAntipsychotic AgentsJournal of paediatrics and child healthReferences
researchProduct

Pulmonale Thrombendarteriektomie bei thromboembolischer pulmonaler Hypertonie: Indikationen und Frühergebnisse

2008

Pulmonary thrombendarterectomy was performed in 32 patients (14 men and 18 women; mean age 38 +/- 15 years) with thromboembolic pulmonary hypertension (New York Heart Association stage III: n = 22; stage IV: n = 10). The preoperative arterial pO2 averaged 59 +/- 11 mm Hg; pulmonary vascular resistance (PVR) and mean pressure (MPAP) were increased to 1,045 +/- 430 dyn.s.cm-5 and 53 +/- 12 mm Hg, respectively. The perioperative death rate was 22% (7 of 32). In the 25 survivors the pulmonary hypertension was reduced to a PVR of 194 +/- 75 dys.s.cm-5, MPAP of 28 +/- 6 mm Hg. Subsequent re-examination in 15 patients (NYHA stage I: n = 14, stage II: n = 1) after a mean of 17 +/- 5 months demonstr…

medicine.medical_specialtybusiness.industryMean pressureGeneral MedicineStage iimedicine.diseasePulmonary hypertensionNew york heart associationmedicine.anatomical_structureEarly resultsInternal medicineVascular resistancemedicineCardiologyStage (cooking)businessThromboembolic pulmonary hypertensionDMW - Deutsche Medizinische Wochenschrift
researchProduct

P2540Sex-specific differences in the clinical presentation, surgical complications, and course of chronic thromboembolic pulmonary hypertension

2019

Abstract Background Women are more susceptible to develop several forms of pulmonary hypertension, but they may have better survival rates than men. Sparse data are available concerning sex-specific differences in chronic thromboembolic pulmonary hypertension (CTEPH). Purpose and methods We investigated sex-specific differences in the clinical presentation of CTEPH, functional parameters, exposure to pulmonary endarterectomy (PEA), and survival. Results Women constituted half of the study population (N=679 treatment-naïve patients from the European CTEPH registry) and were characterized by a lower prevalence of some cardiovascular risk factors (e.g. prior acute coronary syndrome, smoking ha…

medicine.medical_specialtybusiness.industryMedicineChronic thromboembolic pulmonary hypertensionPresentation (obstetrics)Cardiology and Cardiovascular MedicinebusinessIntensive care medicineEuropean Heart Journal
researchProduct